272 related articles for article (PubMed ID: 36309355)
1. Human Papillomavirus Modulates Matrix Metalloproteinases During Carcinogenesis: Clinical Significance and Role of Viral Oncoproteins.
Mendonça F; Teles AM; Nascimento MDDSB; Santos APAD; Lopes FF; Paiva A; Brito HO; DA Costa RG
In Vivo; 2022; 36(6):2531-2541. PubMed ID: 36309355
[TBL] [Abstract][Full Text] [Related]
2. HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis.
Cardeal LB; Boccardo E; Termini L; Rabachini T; Andreoli MA; di Loreto C; Longatto Filho A; Villa LL; Maria-Engler SS
PLoS One; 2012; 7(3):e33585. PubMed ID: 22438955
[TBL] [Abstract][Full Text] [Related]
3. HPV16 oncoproteins promote cervical cancer invasiveness by upregulating specific matrix metalloproteinases.
Kaewprag J; Umnajvijit W; Ngamkham J; Ponglikitmongkol M
PLoS One; 2013; 8(8):e71611. PubMed ID: 23967226
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.
Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
Anticancer Res; 2006; 26(2B):1543-56. PubMed ID: 16619570
[TBL] [Abstract][Full Text] [Related]
5. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
Ryzhakova OS; Solov'eva NI
Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343
[TBL] [Abstract][Full Text] [Related]
6. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
Zhu D; Ye M; Zhang W
Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
[TBL] [Abstract][Full Text] [Related]
7. The Autophagy Process in Cervical Carcinogenesis: Role of Non-Coding-RNAs, Molecular Mechanisms, and Therapeutic Targets.
Lagunas-Martínez A; Madrid-Marina V; Gómez-Cerón C; Deas J; Peralta-Zaragoza O
Cells; 2022 Apr; 11(8):. PubMed ID: 35456001
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins.
Duensing S; Münger K
Int J Cancer; 2004 Mar; 109(2):157-62. PubMed ID: 14750163
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies.
Bhattacharjee R; Das SS; Biswal SS; Nath A; Das D; Basu A; Malik S; Kumar L; Kar S; Singh SK; Upadhye VJ; Iqbal D; Almojam S; Roychoudhury S; Ojha S; Ruokolainen J; Jha NK; Kesari KK
Crit Rev Oncol Hematol; 2022 Jun; 174():103675. PubMed ID: 35381343
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins.
Haręża DA; Wilczyński JR; Paradowska E
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163748
[TBL] [Abstract][Full Text] [Related]
12. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
Kahue CN; Jerrell RJ; Parekh A
Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
[TBL] [Abstract][Full Text] [Related]
13. Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer.
Taghizadeh E; Jahangiri S; Rostami D; Taheri F; Renani PG; Taghizadeh H; Gheibi Hayat SM
Curr Protein Pept Sci; 2019; 20(9):926-934. PubMed ID: 31244421
[TBL] [Abstract][Full Text] [Related]
14. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
15. Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products.
Smola-Hess S; Pahne J; Mauch C; Zigrino P; Smola H; Pfister HJ
J Gen Virol; 2005 May; 86(Pt 5):1291-1296. PubMed ID: 15831939
[TBL] [Abstract][Full Text] [Related]
16. Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers.
Ghosh S; Mazumdar T; Xu W; Powell RT; Stephan C; Shen L; Shah PA; Pickering CR; Myers JN; Wang J; Frederick MJ; Johnson FM
Clin Cancer Res; 2022 Oct; 28(20):4479-4493. PubMed ID: 35972731
[TBL] [Abstract][Full Text] [Related]
17. Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy.
Estêvão D; Costa NR; Gil da Costa RM; Medeiros R
Biochim Biophys Acta Gene Regul Mech; 2019 Feb; 1862(2):153-162. PubMed ID: 30707946
[TBL] [Abstract][Full Text] [Related]
18. MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors.
Luna AJ; Sterk RT; Griego-Fisher AM; Chung JY; Berggren KL; Bondu V; Barraza-Flores P; Cowan AT; Gan GN; Yilmaz E; Cho H; Kim JH; Hewitt SM; Bauman JE; Ozbun MA
PLoS Pathog; 2021 Jan; 17(1):e1009216. PubMed ID: 33481911
[TBL] [Abstract][Full Text] [Related]
19. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
20. Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy.
Vonsky M; Shabaeva M; Runov A; Lebedeva N; Chowdhury S; Palefsky JM; Isaguliants M
Biochemistry (Mosc); 2019 Jul; 84(7):782-799. PubMed ID: 31509729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
